venlafaxine 150 mg
1 INDICATIONS AND USAGE Venlafaxine hydrochloride extended-release capsules are indicated in adults for the treatment of: major depressive disorder (MDD) [see Clinical Studies ( 14.1 )] Generalized Anxiety Disorder (GAD) [see Clinical Studies ( 14.2 )] Social Anxiety Disorder (SAD) [see Clinical Studies ( 14.3 )] Panic Disorder (PD) [see Clinical Studies ( 14.4 )] Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: major depressive disorder (MDD) ( 1 ) Generalized Anxiety Disorder (GAD) ( 1 ) Social Anxiety Disorder (SAD) ( 1 ) Panic Disorder (PD) ( 1 )
Zydus Pharmaceuticals (USA) Inc.
CAPSULE ORANGE ZA 37 150 MG
ZA 37 150 MG CAPSULE ORANGE
Related Pills
venlafaxine as venlafaxine hydrochloride 37.5 MG 24 HR Extended Release Capsule
Zydus Pharmaceuticals (USA) Inc.
venlafaxine 75 mg
zydus pharmaceuticals usa inc.
venlafaxine 150 mg
Zydus Pharmaceuticals (USA) Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
VENLAFAXINE HYDROCHLORIDE Extended-Release capsules USP, 37.5 mg are white to off-white free flowing pellets filled in size '3' hard gelatin capsules with grey colored cap printed with "ZA-35" in black ink & white body printed with "37.5 mg" in black ink and are supplied as follows: NDC 68382-034-06 in bottle of 30 capsules with child-resistant closure NDC 68382-034-16 in bottle of 90 capsules with child-resistant closure NDC 68382-034-10 in bottle of 1,000 capsules
VENLAFAXINE HYDROCHLORIDE Extended-Release capsules USP, 75 mg are white to off-white free flowing pellets filled in size '1' hard gelatin capsules with peach colored cap printed with "ZA-36" in black ink & white body printed with "75 mg" in black ink and are supplied as follows: NDC 68382-035-06 in bottle of 30 capsules with child-resistant closure NDC 68382-035-16 in bottle of 90 capsules with child-resistant closure NDC 68382-035-10 in bottle of 1,000 capsules
VENLAFAXINE HYDROCHLORIDE Extended-Release capsules USP, 150 mg are white to off-white free flowing pellets filled in size '0' hard gelatin capsules with dark orange colored cap printed with "ZA-37" in black ink & white body printed with "150 mg" in black ink and are supplied as follows: NDC 68382-036-06 in bottle of 30 capsules with child-resistant closure NDC 68382-036-16 in bottle of 90 capsules with child-resistant closure NDC 68382-036-10 in bottle of 1,000 capsules Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container.
More pills like CAPSULE ZA 37 150 MG